(JPEF) JPMorgan Equity Focus - Overview
Etf: Common Stocks, REITs, Foreign Depositary Receipts
Dividends
| Dividend Yield | 0.70% |
| Yield on Cost 5y | 1.06% |
| Yield CAGR 5y | 60.12% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.3% |
| Relative Tail Risk | 2.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | -3.86 |
| Character TTM | |
|---|---|
| Beta | 0.911 |
| Beta Downside | 0.932 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.09% |
| CAGR/Max DD | 1.03 |
Description: JPEF JPMorgan Equity Focus January 15, 2026
JPMorgan Equity Focus ETF (NASDAQ:JPEF) is a U.S.-based large-blend fund that allocates at least 80% of its net assets (plus any investment-purpose borrowings) to equity securities, primarily common stocks and REITs. Up to 20% of the portfolio may be invested in foreign equities, including ADRs, giving the fund modest international exposure while staying focused on domestic large-cap growth and value themes.
As of the most recent filing, JPEF carries an expense ratio of 0.30% and manages roughly $1.2 billion in assets, with its top ten holdings concentrated in technology, consumer discretionary, and health-care-sectors that have benefited from sustained earnings growth and resilient consumer spending. The fund’s REIT exposure (≈12% of assets) makes it sensitive to interest-rate dynamics; a 25-basis-point rise in the Fed funds rate typically pressures REIT valuations by increasing borrowing costs and compressing yields.
For investors seeking a data-driven view of how JPEF’s blend of domestic and selective foreign equities performs under varying macro conditions, a deeper dive on ValueRay’s analytics platform can provide the granular metrics needed to assess risk-adjusted returns.
What is the price of JPEF shares?
Over the past week, the price has changed by +0.03%, over one month by +0.41%, over three months by +2.70% and over the past year by +10.44%.
Is JPEF a buy, sell or hold?
What are the forecasts/targets for the JPEF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 83.3 | 10.2% |
JPEF Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.59b USD (1.59b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.59b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.59b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.27% (E(1.59b)/V(1.59b) * Re(9.27%) + (debt-free company))
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)